Twisting IL-1 signaling to kill CML stem cells
Blood
.
2016 Dec 8;128(23):2592-2593.
doi: 10.1182/blood-2016-10-741009.
Authors
Lorenzo Stramucci
1
,
Danilo Perrotti
1
Affiliation
1
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE.
PMID:
27932325
DOI:
10.1182/blood-2016-10-741009
No abstract available
Publication types
Comment
MeSH terms
Humans
Imatinib Mesylate
Interleukin-1*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Neoplastic Stem Cells
Signal Transduction
Stem Cells
Substances
Interleukin-1
Imatinib Mesylate
Grants and funding
R01 CA163800/CA/NCI NIH HHS/United States
R21 CA209183/CA/NCI NIH HHS/United States